Andrei Vladimirovich Murashko
Research Subjects
Andrei Vladimirovich Murashko has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
A F Vanin
3 shared publications- Sidorova I.S. Sidorova
I.M. Sechenov First Moscow State Medical University
3 shared publications - E. N. Burgova
Russian Academy of Sciences
2 shared publications - Ekaterina Valerievna Popova
City Clinical Hospital No. 24
2 shared publications - Raisa A. Chilova
Obstetrics and Gynecology Department No. 1, I. M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia
2 shared publications 3 N.I. Pirogov Russian National Research Medical University of Minzdrav of Russia
1 shared publication
Latest Publications
- Open Access
- 14 November 2026
- Published by ECO-Vector LLC (Publications) in V.F.Snegirev Archives of Obstetrics and Gynecology
- Vol. 13 (3) , 279-290
Preeclampsia as a neuroimmune process: potential diagnostic efficacy of neurogenic and angiogenic markers
BACKGROUND: Preeclampsia (PE) is a multisystem pregnancy complication arising from the 20th week of gestation, coinciding with fetal neurocorticogenesis — formation of the cerebral cortex and higher CNS structures, accompanied by expression of foreign barrier-localized neuron-specific proteins. Current obstetric practice lacks effective methods for prevention, early diagnosis, and therapy of PE, determining the relevance of studying markers of neurocorticogenesis and angiogenic imbalance as diagnostic targets. AIM: To conduct a comparative analysis of the levels of neurogenic markers — neuronal protein NSE, glial S100B, angiogenic factors sFlt, PlGF — and their ratio, as well as the C5 component as a substrate of hyperactivation and dysregulation of the complement system in blood serum of pregnant women with PE, high risk of its development, and physiological pregnancy. METHODS: A single-center cross-sectional study of 82 patients at 22–40 weeks was conducted: main group, 38 with PE; risk group, 22 with risk factors; control group, 22 somatically healthy pregnant women. Levels of NSE, S100B, sFlt-1, PlGF, and C5 were determined by enzyme immunoassay. Statistical analysis was performed using Jamovi version 2.7.37.0. Quantitative markers were compared across the three groups using the nonparametric Kruskal–Wallis test; when statistical differences were found (p 0.05), pairwise comparison was performed using the Mann–Whitney test with Bonferroni correction. ROC analysis was used to determine the diagnostic value of the studied markers. RESULTS: NSE and S100B levels were statistically significantly elevated in the PE group compared with the control group (p 0.001) and the risk group (p 0.001). ROC analysis showed high diagnostic value of NSE and S100B (AUC 0.8) and moderate diagnostic value of the sFlt-1/PlGF ratio (AUC = 0.71). sFlt, PlGF, and the C5 complement component showed low diagnostic value. CONCLUSION: Our study indicates the high scientific and practical significance of studying neurogenic markers with the prospect of introduction into broad clinical practice for early detection of high-risk pregnant women, improving the efficacy of diagnosis and stratification of PE severity, which will change the principles of management of pregnant women, ensuring timely, high-quality, and effective medical care for patients with this condition.
- 14 November 2026
- Published by ECO-Vector LLC (Publications) in V.F.Snegirev Archives of Obstetrics and Gynecology
- Vol. 13 (3) , 279-290
Open AccessPreeclampsia as a neuroimmune process: potential diagnostic efficacy of neurogenic and angiogenic markers
BACKGROUND: Preeclampsia (PE) is a multisystem pregnancy complication arising from the 20th week of gestation, coinciding with fetal neurocorticogenesis — formation of the cerebral cortex and higher CNS structures, accompanied by expression of foreign barrier-localized neuron-specific proteins. Current obstetric practice lacks effective methods for prevention, early diagnosis, and therapy of PE, determining the relevance of studying markers of neurocorticogenesis and angiogenic imbalance as diagnostic targets. AIM: To conduct a comparative analysis of the levels of neurogenic markers — neuronal protein NSE, glial S100B, angiogenic factors sFlt, PlGF — and their ratio, as well as the C5 component as a substrate of hyperactivation and dysregulation of the complement system in blood serum of pregnant women with PE, high risk of its development, and physiological pregnancy. METHODS: A single-center cross-sectional study of 82 patients at 22–40 weeks was conducted: main group, 38 with PE; risk group, 22 with risk factors; control group, 22 somatically healthy pregnant women. Levels of NSE, S100B, sFlt-1, PlGF, and C5 were determined by enzyme immunoassay. Statistical analysis was performed using Jamovi version 2.7.37.0. Quantitative markers were compared across the three groups using the nonparametric Kruskal–Wallis test; when statistical differences were found (p 0.05), pairwise comparison was performed using the Mann–Whitney test with Bonferroni correction. ROC analysis was used to determine the diagnostic value of the studied markers. RESULTS: NSE and S100B levels were statistically significantly elevated in the PE group compared with the control group (p 0.001) and the risk group (p 0.001). ROC analysis showed high diagnostic value of NSE and S100B (AUC 0.8) and moderate diagnostic value of the sFlt-1/PlGF ratio (AUC = 0.71). sFlt, PlGF, and the C5 complement component showed low diagnostic value. CONCLUSION: Our study indicates the high scientific and practical significance of studying neurogenic markers with the prospect of introduction into broad clinical practice for early detection of high-risk pregnant women, improving the efficacy of diagnosis and stratification of PE severity, which will change the principles of management of pregnant women, ensuring timely, high-quality, and effective medical care for patients with this condition.
- Open Access
- 14 November 2026
- Published by ECO-Vector LLC (Publications) in V.F.Snegirev Archives of Obstetrics and Gynecology
- Vol. 13 (3) , 222-228
Features of anesthetic management and anesthetic risks in patients taking combined oral contraceptives and menopausal hormone therapy
This review is based on the analysis of domestic and foreign studies published in peer-reviewed medical journals, and clinical guidelines devoted to anesthetic management of patients receiving combined oral contraceptives and menopausal hormone therapy. For the search of publications, the PubMed database and specialized Russian journals were used. The review included studies published in 1990–2025, with emphasis on systematic reviews, randomized controlled trials, large cohort studies, and current clinical guidelines. Combined oral contraceptives and menopausal hormone therapy are widely used in gynecology; however, they increase the risk of venous thromboembolic complications, especially in the perioperative period. Anesthetic management requires careful assessment of thrombotic risk, consideration of interactions of hormonal drugs with anesthetics, sugammadex, and antibiotics, as well as an individualized approach to continuation or discontinuation of therapy. It is recommended to discontinue oral forms of combined oral contraceptives and menopausal hormone therapy 4–6 weeks before high-risk operations, to give preference to transdermal forms of menopausal hormone therapy, to conduct enhanced thromboprophylaxis with low-molecular-weight heparins, and to mandatory inform patients about the need for additional contraception after the use of sugammadex. Particular attention should be given to patients with thrombophilias and comorbidity. Systematization of data contributes to improving the safety of anesthetic management in this category of patients.
- 14 November 2026
- Published by ECO-Vector LLC (Publications) in V.F.Snegirev Archives of Obstetrics and Gynecology
- Vol. 13 (3) , 222-228
Open AccessFeatures of anesthetic management and anesthetic risks in patients taking combined oral contraceptives and menopausal hormone therapy
This review is based on the analysis of domestic and foreign studies published in peer-reviewed medical journals, and clinical guidelines devoted to anesthetic management of patients receiving combined oral contraceptives and menopausal hormone therapy. For the search of publications, the PubMed database and specialized Russian journals were used. The review included studies published in 1990–2025, with emphasis on systematic reviews, randomized controlled trials, large cohort studies, and current clinical guidelines. Combined oral contraceptives and menopausal hormone therapy are widely used in gynecology; however, they increase the risk of venous thromboembolic complications, especially in the perioperative period. Anesthetic management requires careful assessment of thrombotic risk, consideration of interactions of hormonal drugs with anesthetics, sugammadex, and antibiotics, as well as an individualized approach to continuation or discontinuation of therapy. It is recommended to discontinue oral forms of combined oral contraceptives and menopausal hormone therapy 4–6 weeks before high-risk operations, to give preference to transdermal forms of menopausal hormone therapy, to conduct enhanced thromboprophylaxis with low-molecular-weight heparins, and to mandatory inform patients about the need for additional contraception after the use of sugammadex. Particular attention should be given to patients with thrombophilias and comorbidity. Systematization of data contributes to improving the safety of anesthetic management in this category of patients.
- 31 August 2026
- Published by Bionika Media in Akusherstvo i ginekologiia
- Vol. 8_2026, 101-109
Neuron-specific enolase and angiogenic markers in preeclampsia
- 31 August 2026
- Published by Bionika Media in Akusherstvo i ginekologiia
- Vol. 8_2026, 101-109
Neuron-specific enolase and angiogenic markers in preeclampsia
- 31 March 2026
- Published by Bionika Media in Akusherstvo i ginekologiia
- Vol. 3_2026, 22-29
Fetal brain and preeclampsia: neurodevelopmental disorder and its potential markers
- 31 March 2026
- Published by Bionika Media in Akusherstvo i ginekologiia
- Vol. 3_2026, 22-29
Fetal brain and preeclampsia: neurodevelopmental disorder and its potential markers
- Open Access
- 10 June 2025
- Published by ECO-Vector LLC in V.F.Snegirev Archives of Obstetrics and Gynecology
- Vol. 12 (2) , 255-263
Clinical case of infertility treatment and pregnancy and delivery management following uterine artery embolization for uterine fibroids
Uterine artery embolization is a minimally invasive and effective method for treating symptomatic uterine fibroids; however, its impact on fertility, pregnancy course, and obstetric outcomes remains a topic of ongoing debate. This article presents a clinical case involving the management of a patient with infertility due to uterine factors following uterine artery embolization, which was complicated by non-target embolization of the ovarian vessels. After specialized laser spectral diagnostics of endometrial status and restorative treatment, the patient achieved a spontaneous pregnancy. The pregnancy was complicated by the threat of miscarriage, cervical insufficiency, premature detachment of a normally located placenta, and preterm delivery at 32–33 weeks, as well as prolonged postpartum vaginal bleeding. Additional studies are needed to investigate long-term reproductive outcomes in women following uterine artery embolization and to develop diagnostic and preventive approaches aimed at reducing the risk of complications. The results of this study may contribute to improving the management strategies for patients with similar complications and serve as a basis for developing treatment guidelines.
- 10 June 2025
- Published by ECO-Vector LLC in V.F.Snegirev Archives of Obstetrics and Gynecology
- Vol. 12 (2) , 255-263
Open AccessClinical case of infertility treatment and pregnancy and delivery management following uterine artery embolization for uterine fibroids
Uterine artery embolization is a minimally invasive and effective method for treating symptomatic uterine fibroids; however, its impact on fertility, pregnancy course, and obstetric outcomes remains a topic of ongoing debate. This article presents a clinical case involving the management of a patient with infertility due to uterine factors following uterine artery embolization, which was complicated by non-target embolization of the ovarian vessels. After specialized laser spectral diagnostics of endometrial status and restorative treatment, the patient achieved a spontaneous pregnancy. The pregnancy was complicated by the threat of miscarriage, cervical insufficiency, premature detachment of a normally located placenta, and preterm delivery at 32–33 weeks, as well as prolonged postpartum vaginal bleeding. Additional studies are needed to investigate long-term reproductive outcomes in women following uterine artery embolization and to develop diagnostic and preventive approaches aimed at reducing the risk of complications. The results of this study may contribute to improving the management strategies for patients with similar complications and serve as a basis for developing treatment guidelines.
- Open Access
- 22 December 2024
- Published by ECO-Vector LLC in V.F.Snegirev Archives of Obstetrics and Gynecology
- Vol. 11 (4) , 490-498
Pregnancy vomiting obscuring other disease: a clinical case of Wernicke encephalopathy
The article presents a clinical case of Wernicke encephalopathy occurring as complication of excessive pregnancy-related vomiting (hyperemesis gravidarum). This disorder has developed due to thiamine (vitamin B1) deficiency. The correct diagnosis is challenging due to the similarity of clinical manifestations with several other disorders. Timely diagnosis and early treatment reduce the risk of severe course and irreversible complications that can lead to the potentially adverse outcome. This case is remarkable due to the appearance of the disease in a 32-year-old pregnant woman with excessive vomiting. The patient demonstrated the classic symptom triad found in only 16% of patients with Wernicke encephalopathy. Primarily ataxia and nystagmus appeared, and later memory impairment with confabulations was recorded. Magnetic resonance imaging of the brain revealed bilateral symmetrical areas with increased MR signal intensity in T2 (SE and FLAIR) sequences in the mediodorsal nucleus (MD) of thalamus, subependymal microglia of the III ventricle, and periaqueductal gray. The treatment of Wernicke encephalopathy was immediately initiated with the use of intravenous thiamine 200 mg 3 times daily. The beneficial treatment effect was reported. Further pregnancy proceeded unremarkably and resulted in the birth of a live term girl. During the postpartum period, the patient reported persisting instability when walking, which increased with closed eyes, and non-systemic dizziness.
- 22 December 2024
- Published by ECO-Vector LLC in V.F.Snegirev Archives of Obstetrics and Gynecology
- Vol. 11 (4) , 490-498
Open AccessPregnancy vomiting obscuring other disease: a clinical case of Wernicke encephalopathy
The article presents a clinical case of Wernicke encephalopathy occurring as complication of excessive pregnancy-related vomiting (hyperemesis gravidarum). This disorder has developed due to thiamine (vitamin B1) deficiency. The correct diagnosis is challenging due to the similarity of clinical manifestations with several other disorders. Timely diagnosis and early treatment reduce the risk of severe course and irreversible complications that can lead to the potentially adverse outcome. This case is remarkable due to the appearance of the disease in a 32-year-old pregnant woman with excessive vomiting. The patient demonstrated the classic symptom triad found in only 16% of patients with Wernicke encephalopathy. Primarily ataxia and nystagmus appeared, and later memory impairment with confabulations was recorded. Magnetic resonance imaging of the brain revealed bilateral symmetrical areas with increased MR signal intensity in T2 (SE and FLAIR) sequences in the mediodorsal nucleus (MD) of thalamus, subependymal microglia of the III ventricle, and periaqueductal gray. The treatment of Wernicke encephalopathy was immediately initiated with the use of intravenous thiamine 200 mg 3 times daily. The beneficial treatment effect was reported. Further pregnancy proceeded unremarkably and resulted in the birth of a live term girl. During the postpartum period, the patient reported persisting instability when walking, which increased with closed eyes, and non-systemic dizziness.
- Open Access
- 7 October 2024
- Published by ECO-Vector LLC in V.F.Snegirev Archives of Obstetrics and Gynecology
- Vol. 11 (3) , 233-244
Current possibilities and prospects of tocolytic therapy
The urgency of the problem of preterm birth (PB) is because of its high prevalence and neonatal mortality. The effects of PB on the fetus are often fatal, and PB accounts for 70% of neonatal mortality and 36% of infant mortality. Severe neurological deficits (e.g., cerebral palsy, epilepsy, intraventricular hemorrhages, retinopathy, blindness, hearing loss, delayed neuropsychiatric and motor development) occur in 68% of surviving premature infants. Additionally, children born prematurely have a high risk for purulent septic diseases. The metabolic consequences of prematurity cause diseases such as metabolic syndrome and hypertension. Thus, tocolytic therapy is a crucial therapeutic measure in obstetrics. However, most known and actively used tocolytic drugs induce insufficient effect for long-term prolongation of pregnancy or have serious side effects. Currently, there is a search for new tocolytics to obtain safe, adequate, and long-term effects. This review examines promising and relevant drugs that may be used in routine obstetric practice. Scientific articles, meta-analyses, and systematic reviews from the databases PubMed, Embase, Web of Science, and Google Scholar, and RSCI were analyzed. For the analysis, publications in English and posted no more than 5 years before the study was conducted were selected, except for fundamental works with a longer publication period.
- 7 October 2024
- Published by ECO-Vector LLC in V.F.Snegirev Archives of Obstetrics and Gynecology
- Vol. 11 (3) , 233-244
Open AccessCurrent possibilities and prospects of tocolytic therapy
The urgency of the problem of preterm birth (PB) is because of its high prevalence and neonatal mortality. The effects of PB on the fetus are often fatal, and PB accounts for 70% of neonatal mortality and 36% of infant mortality. Severe neurological deficits (e.g., cerebral palsy, epilepsy, intraventricular hemorrhages, retinopathy, blindness, hearing loss, delayed neuropsychiatric and motor development) occur in 68% of surviving premature infants. Additionally, children born prematurely have a high risk for purulent septic diseases. The metabolic consequences of prematurity cause diseases such as metabolic syndrome and hypertension. Thus, tocolytic therapy is a crucial therapeutic measure in obstetrics. However, most known and actively used tocolytic drugs induce insufficient effect for long-term prolongation of pregnancy or have serious side effects. Currently, there is a search for new tocolytics to obtain safe, adequate, and long-term effects. This review examines promising and relevant drugs that may be used in routine obstetric practice. Scientific articles, meta-analyses, and systematic reviews from the databases PubMed, Embase, Web of Science, and Google Scholar, and RSCI were analyzed. For the analysis, publications in English and posted no more than 5 years before the study was conducted were selected, except for fundamental works with a longer publication period.
- Open Access
- 11 July 2024
- Published by ECO-Vector LLC in V.F.Snegirev Archives of Obstetrics and Gynecology
- Vol. 11 (2) , 125-136
Ultrasound examination in the antenatal diagnosis of placenta accreta spectrum
The rise in cesarean section rates worldwide has greatly increased the rates of placenta accreta spectrum. Accurate diagnostics of placenta accreta spectrum before delivery is still difficult, as one-half to two-thirds of placenta accreta spectrum cases remain undiagnosed until delivery. Local and foreign studies reported the diagnostic accuracy of ultrasonography (US) as the most commonly used method for placenta accreta spectrum imaging because of its inexpensiveness, noninvasiveness, and swiftness. This review highlighted the possibilities of prenatal US diagnosis of placenta accreta spectrum. Diagnostic accuracy may be reduced by the localization of the placenta in the posterior wall and a higher body mass index. US and magnetic resonance imaging (MRI) are highly specific and useful in diagnosing or ruling out placenta accreta spectrum. Unlike MRI, the accuracy of US depends on the qualification; therefore, single-center studies often overestimate the accuracy of US. More studies of the diagnostic methods for placenta accreta spectrum are needed for the selection of logical obstetric techniques for managing pregnant women with this pathology.
- 11 July 2024
- Published by ECO-Vector LLC in V.F.Snegirev Archives of Obstetrics and Gynecology
- Vol. 11 (2) , 125-136
Open AccessUltrasound examination in the antenatal diagnosis of placenta accreta spectrum
The rise in cesarean section rates worldwide has greatly increased the rates of placenta accreta spectrum. Accurate diagnostics of placenta accreta spectrum before delivery is still difficult, as one-half to two-thirds of placenta accreta spectrum cases remain undiagnosed until delivery. Local and foreign studies reported the diagnostic accuracy of ultrasonography (US) as the most commonly used method for placenta accreta spectrum imaging because of its inexpensiveness, noninvasiveness, and swiftness. This review highlighted the possibilities of prenatal US diagnosis of placenta accreta spectrum. Diagnostic accuracy may be reduced by the localization of the placenta in the posterior wall and a higher body mass index. US and magnetic resonance imaging (MRI) are highly specific and useful in diagnosing or ruling out placenta accreta spectrum. Unlike MRI, the accuracy of US depends on the qualification; therefore, single-center studies often overestimate the accuracy of US. More studies of the diagnostic methods for placenta accreta spectrum are needed for the selection of logical obstetric techniques for managing pregnant women with this pathology.
- Open Access
- 11 October 2023
- Published by ECO-Vector LLC in V.F.Snegirev Archives of Obstetrics and Gynecology
- Vol. 10 (3) , 187-193
Peripheral neuropathy occurring during pregnancy (literature review)
Peripheral neuropathy is a general scientific term used to describe disorders of the peripheral nerves of any etiology. Along with postinfectious, diabetic, paraneoplastic, and alcoholic neuropathy, neuropathy of pregnancy represents one of the forms of this pathology. In this study, the authors conducted an analysis of domestic and foreign literature from open sources over the past 20 years. The study of available data revealed that the most common peripheral neuropathies observed during pregnancy are carpal tunnel syndrome, Bells palsy, and neuropathies affecting the lower extremities. Despite the paucity of information on peripheral neuropathy in pregnant women, its relevance is very high as it can significantly impair the quality of life during pregnancy and does not always disappear immediately after delivery, sometimes persisting for a certain period of time. The literature search was conducted in Scopus, Web of Science, PubMed, ScienceDirect, CyberLeninka, and RSCI databases using the following keywords: pregnancy; neuropathy; carpal tunnel syndrome; Bells palsy; review.
- 11 October 2023
- Published by ECO-Vector LLC in V.F.Snegirev Archives of Obstetrics and Gynecology
- Vol. 10 (3) , 187-193
Open AccessPeripheral neuropathy occurring during pregnancy (literature review)
Peripheral neuropathy is a general scientific term used to describe disorders of the peripheral nerves of any etiology. Along with postinfectious, diabetic, paraneoplastic, and alcoholic neuropathy, neuropathy of pregnancy represents one of the forms of this pathology. In this study, the authors conducted an analysis of domestic and foreign literature from open sources over the past 20 years. The study of available data revealed that the most common peripheral neuropathies observed during pregnancy are carpal tunnel syndrome, Bells palsy, and neuropathies affecting the lower extremities. Despite the paucity of information on peripheral neuropathy in pregnant women, its relevance is very high as it can significantly impair the quality of life during pregnancy and does not always disappear immediately after delivery, sometimes persisting for a certain period of time. The literature search was conducted in Scopus, Web of Science, PubMed, ScienceDirect, CyberLeninka, and RSCI databases using the following keywords: pregnancy; neuropathy; carpal tunnel syndrome; Bells palsy; review.
- 15 January 2022
- Published by ECO-Vector LLC in V.F.Snegirev Archives of Obstetrics and Gynecology
- Vol. 9 (1) , 5-12
The role of integrins in the formation of the placental increment (placenta accreta spectrum)
One of the most serious pregnancy complications is currently considered as a violation of cytotrophoblast invasion, particularly, a pathologically increased depth of invasion, leading to the formation of the placental increment (placenta accreta), ingrowth (placenta increta), and germination (placenta percreta). Cytotrophoblast invasion is regulated through subtle intercellular interactions, an important role among which is played by integrins, transmembrane glycoproteins that contribute to the immersion of cytotrophoblast in the endometrium and myometrium. The balance disturbance in the expression of 11, 51, and 64 integrins after normal implantation form a pathological extravillous trophoblast (EVT) phenotype by the blastocyst. This review examines the importance of integrins, collagens, and fibronectin in the formation of placental ingrowth (placenta accreta spectrum).
- 15 January 2022
- Published by ECO-Vector LLC in V.F.Snegirev Archives of Obstetrics and Gynecology
- Vol. 9 (1) , 5-12
The role of integrins in the formation of the placental increment (placenta accreta spectrum)
One of the most serious pregnancy complications is currently considered as a violation of cytotrophoblast invasion, particularly, a pathologically increased depth of invasion, leading to the formation of the placental increment (placenta accreta), ingrowth (placenta increta), and germination (placenta percreta). Cytotrophoblast invasion is regulated through subtle intercellular interactions, an important role among which is played by integrins, transmembrane glycoproteins that contribute to the immersion of cytotrophoblast in the endometrium and myometrium. The balance disturbance in the expression of 11, 51, and 64 integrins after normal implantation form a pathological extravillous trophoblast (EVT) phenotype by the blastocyst. This review examines the importance of integrins, collagens, and fibronectin in the formation of placental ingrowth (placenta accreta spectrum).